Multicenter prospective evaluation of the reliability of the combined use of two models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: the MSKCC nomogram and the Tenon score. Results of the NOTEGS study

[1]  Lesley Fallowfield,et al.  Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  R. Rouzier,et al.  Impact of axillary dissection in women with invasive breast cancer who do not fit the Z0011 ACOSOG trial because of three or more metastatic sentinel lymph nodes. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[3]  E. Mccaig,et al.  Sentinel Node Biopsy Alone versus Completion Axillary Node Dissection in Node Positive Breast Cancer: Systematic Review and Meta-Analysis , 2014, International journal of breast cancer.

[4]  M. Morrow,et al.  The Extent of Extracapsular Extension May Influence the Need for Axillary Lymph Node Dissection in Patients with T1–T2 Breast Cancer , 2014, Annals of Surgical Oncology.

[5]  A. Luini,et al.  Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. , 2013, The Lancet. Oncology.

[6]  C. Coutant,et al.  The Exportability of the ACOSOG Z0011 Criteria for Omitting Axillary Lymph Node Dissection After Positive Sentinel Lymph Node Biopsy Findings: A Multicenter Study , 2013, Annals of Surgical Oncology.

[7]  F. Su,et al.  Which nomogram is best for predicting non-sentinel lymph node metastasis in breast cancer patients? A meta-analysis , 2013, Breast Cancer Research and Treatment.

[8]  A. Giuliano,et al.  Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. , 2011, JAMA.

[9]  E. Darai,et al.  Prospective multicenter comparison of models to predict four or more involved axillary lymph nodes in patients with breast cancer with one to three metastatic sentinel lymph nodes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  E. Darai,et al.  Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study. , 2009, Journal of Clinical Oncology.

[11]  E. Darai,et al.  Validation of the Tenon breast cancer score for predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter study , 2009, Breast Cancer Research and Treatment.

[12]  Solomon Henry,et al.  New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients , 2008, BMC Cancer.

[13]  E. Winer,et al.  American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  W. Gerald,et al.  Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy , 2005, Cancer.

[15]  Antoine Flahault,et al.  An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement , 2005, Breast Cancer Research and Treatment.

[16]  Joseph G. Ibrahim,et al.  Non‐ignorable missing covariate data in survival analysis: a case‐study of an International Breast Cancer Study Group trial , 2004 .

[17]  Hiram S. Cody,et al.  A Nomogram for Predicting the Likelihood of Additional Nodal Metastases in Breast Cancer Patients With a Positive Sentinel Node Biopsy , 2003, Annals of Surgical Oncology.

[18]  A E Giuliano,et al.  Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? , 1999, Annals of surgery.

[19]  A. Feinstein,et al.  Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. , 1978, The New England journal of medicine.

[20]  Frcsc Éric Poirier MD,et al.  Analysis of Clinical Applicability of the Breast Cancer Nomogram for Positive Sentinel Lymph Node: The Canadian Experience , 2008, Annals of Surgical Oncology.